�ke Borg

897 total citations
13 papers, 697 citations indexed

About

�ke Borg is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, �ke Borg has authored 13 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in �ke Borg's work include BRCA gene mutations in cancer (6 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Genomics and Diagnostics (4 papers) �ke Borg is often cited by papers focused on BRCA gene mutations in cancer (6 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Genomics and Diagnostics (4 papers) �ke Borg collaborates with scholars based in Sweden, Finland and Netherlands �ke Borg's co-authors include Jorma Isola, Håkan Olsson, Niklas Loman, Minna Tanner, Fredrik Mertens, Oskar T. Johannsson, Johan Wennerberg, Yuesheng Jin, Rob Michalides and Hiroyuki Mineta and has published in prestigious journals such as Cancer, International Journal of Cancer and Breast Cancer Research and Treatment.

In The Last Decade

�ke Borg

13 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
�ke Borg Sweden	12	349	334	314	215	132	13	697
Chandramohan S. Ishwad United States	14	158 0.5×	311 0.9×	110 0.4×	132 0.6×	78 0.6×	20	547
Sanne R. Martens‐de Kemp Netherlands	13	227 0.7×	337 1.0×	85 0.3×	167 0.8×	76 0.6×	18	578
C. Weber United States	4	428 1.2×	389 1.2×	105 0.3×	121 0.6×	73 0.6×	7	796
John C. Law United States	12	326 0.9×	377 1.1×	86 0.3×	141 0.7×	67 0.5×	16	658
Roelof J.C. Kluin Netherlands	9	412 1.2×	295 0.9×	91 0.3×	128 0.6×	113 0.9×	12	751
Anne‐Lise Børresen‐Dale Norway	11	315 0.9×	323 1.0×	76 0.2×	262 1.2×	87 0.7×	17	627
Rüdiger G. Steinbeck Sweden	9	302 0.9×	353 1.1×	300 1.0×	325 1.5×	333 2.5×	14	892
Catherine Dugast France	11	165 0.5×	350 1.0×	296 0.9×	185 0.9×	171 1.3×	26	682
A S Yang United States	5	278 0.8×	569 1.7×	79 0.3×	136 0.6×	91 0.7×	6	734
Norbert Arens Germany	15	251 0.7×	211 0.6×	80 0.3×	264 1.2×	83 0.6×	22	572

Countries citing papers authored by �ke Borg

Since Specialization

Citations

This map shows the geographic impact of �ke Borg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by �ke Borg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites �ke Borg more than expected).

Fields of papers citing papers by �ke Borg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by �ke Borg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by �ke Borg. The network helps show where �ke Borg may publish in the future.

Co-authorship network of co-authors of �ke Borg

This figure shows the co-authorship network connecting the top 25 collaborators of �ke Borg. A scholar is included among the top collaborators of �ke Borg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with �ke Borg. �ke Borg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Thorstenson, Sten, et al.. (2001). Deletion mapping of chromosome segment 11q24-q25, exhibiting extensive allelic loss in early onset breast cancer. International Journal of Cancer. 92(2). 208–213. 18 indexed citations

Emanuelsson, Monica, et al.. (2001). BRCA2 mutation in a family with hereditary prostate cancer. Genes Chromosomes and Cancer. 30(3). 299–301. 21 indexed citations

Staff, Synnöve, Nina N. Nupponen, �ke Borg, Jorma Isola, & Minna M. Tanner. (2000). Multiple copies of mutantBRCA1 andBRCA2 alleles in breast tumors from germ-line mutation carriers. Genes Chromosomes and Cancer. 28(4). 432–442. 27 indexed citations

Borg, �ke, Jorma Isola, Jindong Chen, et al.. (2000). GermlineBRCA1 andHMLH1 mutations in a family with male and female breast carcinoma. International Journal of Cancer. 85(6). 796–800. 23 indexed citations

Koul, Anjila, Mef Nilbert, & �ke Borg. (1999). A somaticBRCA2 mutation in RER+ endometrial carcinomas that specifically deletes the amino-terminal transactivation domain. Genes Chromosomes and Cancer. 24(3). 207–212. 19 indexed citations

Planck, Maria, Anjila Koul, Eva Fernebro, et al.. (1999). hMLH1, hMSH2 andhMSH6 mutations in hereditary non-polyposis colorectal cancer families from Southern Sweden. International Journal of Cancer. 83(2). 197–202. 25 indexed citations

Tirkkonen, Mika, Tommi Kainu, Niklas Loman, et al.. (1999). Somatic genetic alterations inBRCA2-associated and sporadic male breast cancer. Genes Chromosomes and Cancer. 24(1). 56–61. 49 indexed citations

Persson, Karin, Nikos Pandis, Fredrik Mertens, et al.. (1999). Chromosomal aberrations in breast cancer: A comparison between cytogenetics and comparative genomic hybridization. Genes Chromosomes and Cancer. 25(2). 115–122. 34 indexed citations

Tanner, Minna, et al.. (1999). Characterization of topoisomerase II? gene amplification and deletion in breast cancer. Genes Chromosomes and Cancer. 26(2). 142–150. 130 indexed citations

10.

Loman, Niklas, et al.. (1998). Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer. 83(2). 310–319. 139 indexed citations

11.

Hedenfalk, Ingrid, Bo Baldetorp, �ke Borg, & Stina Oredsson. (1997). Activated cell cycle checkpoints in epirubicin-treated breast cancer cells studied by BrdUrd-flow cytometry. Cytometry. 29(4). 321–327. 7 indexed citations

12.

Michalides, Rob, Hiroyuki Mineta, Alfons J. M. Balm, et al.. (1997). Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer. 79(2). 380–389. 182 indexed citations

13.

Baldetorp, Bo, et al.. (1995). Recurrence-free survival in breast cancer improved by adjuvant tamoxifen -especially for progesterone receptor positive tumors with a high proliferation. Breast Cancer Research and Treatment. 36(1). 23–34. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact